MediPharm Labs Shareholders Equity (Quarterly) Analysis

MediPharm Labs Corp (LABS.TO)

0.075 0.00 (0.00%) CAD | TSX | May 28, 15:18

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	49.86M
December 31, 2023	53.00M
September 30, 2023	55.20M
June 30, 2023	59.01M
March 31, 2023	53.66M
December 31, 2022	56.00M
September 30, 2022	60.48M
June 30, 2022	68.57M
March 31, 2022	76.16M
December 31, 2021	83.15M
September 30, 2021	102.62M
June 30, 2021	109.53M
March 31, 2021	118.76M

Date	Value
December 31, 2020	78.41M
September 30, 2020	105.39M
June 30, 2020	117.98M
March 31, 2020	118.66M
December 31, 2019	131.55M
September 30, 2019	128.98M
June 30, 2019	121.02M
March 31, 2019	34.26M
September 30, 2018	0.4271M
June 30, 2018	0.4964M
March 31, 2018	0.5124M
December 31, 2017	0.3781M
September 30, 2017	0.40M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

49.86M

Minimum

Mar 2024

131.55M

Maximum

Dec 2019

87.40M

Average

80.78M

Median

Shareholders Equity (Quarterly) Benchmarks

Biocure Technology Inc	1.603M
Core One Labs Inc	5.641M
Nova Mentis Life Science Corp	-0.601M
Nanosphere Health Sciences Inc	-2.064M
Lobe Sciences Ltd	-1.235M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly)	61.24M
Total Liabilities (Quarterly)	11.39M
Debt to Equity Ratio	0.0397
Current Ratio	3.069
Net Debt Paydown Yield	-0.90%